PYOTT DAVID E I

CIK 00010515787 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001051578

Recent Transactions

50 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-02-18+5,893→ 5,893 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-02-18+3,729→ 3,729 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2025-06-05+30,000→ 30,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-08+775→ 911 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-03-24$88.95/sh+7,440→ 7,576 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-03-24−7,440→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-03-24$299.00/sh−7,440→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$71.99/sh+7,470→ 32,586 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$220.00/sh−17,560→ 15,026 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$70.20/sh+7,420→ 25,116 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-24−7,470→ 3,780 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$88.95/sh+17,560→ 17,696 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$221.00/sh−7,420→ 7,606 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-24−17,560→ 7,440 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$222.00/sh−7,470→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-24−7,420→ 3,830 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2024-06-13+26,764→ 26,764 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-21+4,720→ 49,750 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-16+5,228→ 5,228 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2023-06-07+14,000→ 14,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-05-23+4,190→ 45,030 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-05-18+3,454→ 3,454 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-23+136→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-02-23−136→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-06-16+15,000→ 15,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-05-24+4,980→ 40,840 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-05-18+5,153→ 5,153 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2022-02-23+136→ 136 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-07-15+4,032→ 4,032 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-06-29+13,286→ 13,286 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-06-29+13,286→ 13,286 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-05-25+5,120→ 35,860 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-01-12+26,573→ 26,573 total
Purchase
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-08-31$78.84/sh+900→ 30,740 total
Purchase
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-08-31$78.22/sh+11,900→ 29,840 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2020-07-01+4,581→ 4,581 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-05-27+4,300→ 17,940 total
Exercise/Conversion
Avery Dennison Corp$AVY
Common Stock
2020-04-23$107.56/sh+1,414→ 18,684 total
Exercise/Conversion
Avery Dennison Corp$AVY
2019 Director RSU Award
2020-04-23−1,414→ 0 total
Sale
Avery Dennison Corp$AVY
Common Stock
2020-02-03$132.72/sh−5,027→ 17,270 total
Exercise/Conversion
Avery Dennison Corp$AVY
Common Stock
2020-02-03$38.18/sh+5,027→ 22,297 total
Exercise/Conversion
Avery Dennison Corp$AVY
2010 Director Stock Option
2020-02-03−5,027→ 0 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2019-07-01+9,000→ 9,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-06-04+4,430→ 13,640 total
Exercise/Conversion
Avery Dennison Corp$AVY
2016 Director RSU Award
2019-05-01−641→ 0 total
Exercise/Conversion
Avery Dennison Corp$AVY
2018 Director RSU Award
2019-05-01−1,336→ 0 total
Exercise/Conversion
Avery Dennison Corp$AVY
Common Stock
2019-05-01$109.63/sh+641→ 15,934 total
Award
Avery Dennison Corp$AVY
2019 Director RSU Award
2019-05-01+1,414→ 1,414 total
Exercise/Conversion
Avery Dennison Corp$AVY
Common Stock
2019-05-01$109.63/sh+1,336→ 17,270 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov